25 citations
,
August 2015 in “Journal of cosmetic dermatology”
African American women report more hair issues and use different hair care practices than Caucasian women, and have different hair and scalp characteristics.
The FDA policy change may speed up approval for hair loss drugs like PP405, VDPHL-01, and Breezula by potentially eliminating the need for a second confirmatory Phase 3 trial. Approval timelines could be as early as 2028 for some treatments if Phase 3 results are strong.
Hair growth relies on mechanical forces, not just chemicals, with tissue acting like a motor. Minoxidil and finasteride help, but maintaining tissue elasticity and addressing mechanical issues are essential.
GT20029 is a new hair loss treatment in Phase 3 trials in China, using PROTAC technology to target androgen receptors, potentially with fewer side effects than finasteride and minoxidil. VDPHL01, a second-generation minoxidil, is also mentioned as potentially more effective.
Curly and wavy hair can make hair loss appear worse due to clumping, but using less product, shorter cuts, and leave-in conditioner can help manage appearance. Minoxidil and finasteride are considered for treatment, and some find that styling can hide thinning areas.